KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $829.0 million.

  • Bristol Myers Squibb's Change in Acquisitions & Divestments rose 24831.93% to $829.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 4850.14%. This contributed to the annual value of $1.1 billion for FY2024, which is 5306.96% up from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Change in Acquisitions & Divestments is $829.0 million, which was up 24831.93% from $524.0 million recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Change in Acquisitions & Divestments peaked at $2.1 billion during Q1 2022, and registered a low of $41.0 million during Q4 2023.
  • Over the past 5 years, Bristol Myers Squibb's median Change in Acquisitions & Divestments value was $747.0 million (recorded in 2024), while the average stood at $738.7 million.
  • Per our database at Business Quant, Bristol Myers Squibb's Change in Acquisitions & Divestments plummeted by 9704.76% in 2023 and then surged by 110483.87% in 2024.
  • Bristol Myers Squibb's Change in Acquisitions & Divestments (Quarter) stood at $1.2 billion in 2021, then dropped by 3.05% to $1.2 billion in 2022, then crashed by 96.6% to $41.0 million in 2023, then skyrocketed by 51.22% to $62.0 million in 2024, then soared by 1237.1% to $829.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $829.0 million in Q3 2025, compared to $524.0 million in Q2 2025 and $220.0 million in Q1 2025.